Current classification of antiarrhythtalc drugs;Aktuelle einteilung antiarrhythmisch wirksamer substanzen

Zeitschrift fur Kardiologie

Volumn 89, Issue SUPPL. 3, 2000, Pages

  Weirich, Jörg ^a   Wenzel, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antiarrhythmic drugs; Dependence; Frequency; Ion channel blockade; Proarrhythmic effects

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; LIDOCAINE; MEXILETINE; NADOLOL; POTASSIUM CHANNEL BLOCKING AGENT; PROPAFENONE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; VERAPAMIL;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HUMAN; TREATMENT INDICATION;

EID: 0343238438     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070086     Document Type: Article

References (24)

1. Antoni H, Weirich J (1996) Ursachen tachykarder Herzrhythmusstörungen: Neue elektrophysiologische Erkenntnisse. Internist 37: 3-11
2. Antoni H, Weirich J (1990) Neue Aspekte der elektrophysiologischen Wirkung von Antiarrhythmika. Herz 15: 61-69
3. Ks cardiac potassium current. Nature 384: 78-80
4. Campbell TJ (1983) Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle and provide a theoretical basis for their subclassification. Cardiovascular Research 17: 344-352
5. Carmeliet E, Mubagwa K (1998) Antiarrhythmic drugs an cardiac ion channels: mechanisms of action. Progress in Biophysics & Molecular Biology 70: 1-72
6. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406-412
7. Colatsky TJ, Follmer CH, Starmer CF (1990) Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82: 2235-2242
8. Heistracher P (1971) Mechanisms of action of antifibrillatory drugs. NaunynSchmiedeberg's Arch Pharmacol 269: 199-212
9. Hille B (1977) Local anesthetics: hydrophilic and Hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69: 497-515
10. Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium-channels. Biochimica et Biophysica Acta 472: 373-398
11. Hondeghem LM, Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Circulation 81: 686-690
12. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M (1988) The long QT syndromes: a critical review, new clinical observations and unifying hypothesis. Progress in Cardiovascular Diseases 31: 115-172
13. January CT, Riddle JM, Salata JJ (1988) A model for early afterdepolarizations: Induction with Ca-channel antagonist Bay K 8644. Circ Res 72: 75-83
14. + current by dofetilide. Circ Res 72: 75-83
15. Ranger S, Talajic M, Lemery R, Roy D, Nattel S (1989) Amplification of flecainide-induced ventricular conduction slowing by exercise. Circulation 79: 1000-1006
16. Ks potassium channel. Nature 384: 80-83
17. Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophysical Journal 46: 15
18. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84: 1831-1851
19. Vaughan Williams EM (1979) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen KH (eds) Cardiac Arrhthmias. Sodertalje, Sweden, Astra, pp 449-472
20. Wang J, Feng J, Nattel S (1994) Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol an the new antiarrhythmic drug ambasilide. Circulation 90: 2032-2040
21. Weirich J, Antoni H (1990) Differential analysis of the frequency-dependent effects of class-I-antiarrhythmic drugs according to periodical ligand binding: Implications on antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharmacol 15: 998-1009
22. Weirich J (1992) Frequency-dependent action of antiarrhythmic drugs: The useful concept of periodical ligand binding. Basic Research in Cardiology 8: 205-214
23. Kr-channel blocking antiarrhythmic agents. Pflügers Arch 435 (Suppl 6): R 79
24. + current in ventricular myocytes of the guinea pig type. Circ Res 77: 140-152